# NDRA (Endra Life Sciences Inc.) - SEC EDGAR Financial Statements

> Endra Life Sciences Inc. reported $6.72M in total assets and a net loss of $5.85M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/NDRA
- Markdown: https://convexityos.com/fundamentals/NDRA.md
- SEC CIK: 0001681682
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001681682&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$6.99M | Operating profit |
| Net Income | FY 2025 | -$5.85M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.90 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$5.20M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.52M | Total debt: $397K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | $0 | $0 | $6.2K | $352K | $516K |
| Cost of Revenue | -- | -- | -- | -- | -- | $0 | $0 | $0 | $173K | -- |
| **Gross Profit** | -- | -- | -- | -- | -- | $0 | $0 | $6.2K | $179K | $280K |
| Research & Development | $1.85M | $3.19M | $5.00M | $6.55M | $5.48M | $5.92M | $6.57M | $4.72M | $1.93M | $495K |
| Selling, General & Admin | $3.91M | $7.63M | $5.52M | $6.60M | $6.02M | $5.58M | $4.27M | $4.02M | $2.87M | $1.58M |
| Total Operating Expenses | $5.76M | $10.82M | $10.52M | $13.16M | $11.50M | $11.50M | $10.84M | $9.03M | $4.80M | $2.07M |
| **Operating Income** | -$5.76M | -$10.82M | -$10.52M | -$13.16M | -$11.50M | -$11.50M | -$10.84M | -$9.02M | -$4.63M | -$1.79M |
| **EBITDA** | -$5.72M | -$10.77M | -$10.40M | -$13.06M | -$11.38M | -$11.40M | -$10.76M | -$8.95M | -$4.56M | -$1.73M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $0 | $43K | $72K |
| Income Before Tax | -$7.03M | -$11.51M | -$10.06M | -$13.18M | -$11.23M | -$11.73M | -$13.31M | -$9.80M | -$5.38M | -$2.78M |
| Income Tax Expense | -- | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$7.03M | -$11.51M | -$10.06M | -$13.18M | -$11.23M | -$11.73M | -$13.31M | -$9.80M | -$5.38M | -$2.78M |
| Basic EPS | -$8.93 | -$56.94 | -- | -$4.56 | -$5.55 | -$0.63 | -$2.34 | -$2.17 | -$1.95 | -$3.84 |
| **Diluted EPS** | -$8.93 | -$56.94 | -$2,766.85 | -- | -- | -$0.63 | -$2.34 | -$2.17 | -$1.95 | -$3.84 |
| Basic Shares Outstanding | 787.0K | 202.1K | -- | -- | -- | 19.2M | 7.5M | 4.5M | 2.8M | 723.3K |
| Diluted Shares Outstanding | 787.0K | 202.1K | 3.6K | -- | -- | 19.2M | 7.5M | 4.5M | 2.8M | 723.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $176K | $234K | $776K | $508K | $432K | $381K | $529K | $638K |
| Selling, General & Admin | $1.54M | $1.25M | $1.40M | $1.11M | $939K | $920K | $941K | $3.66M |
| Total Operating Expenses | $1.72M | $1.48M | $2.17M | $1.62M | $1.37M | $1.30M | $1.47M | $4.30M |
| **Operating Income** | -$1.72M | -$1.48M | -$2.17M | -$1.62M | -$1.37M | -$1.30M | -$1.47M | -$4.30M |
| **EBITDA** | -$1.71M | -$1.48M | -$2.16M | -$1.61M | -$1.36M | -$1.29M | -$1.46M | -$4.29M |
| Income Before Tax | -$1.53M | $160K | -$1.31M | -$3.17M | -$1.60M | -$1.23M | -$1.04M | -$4.15M |
| Income Tax Expense | -- | -- | -- | -- | -- | $0 | $0 | -- |
| **Net Income** | -$1.53M | $160K | -$1.31M | -$3.17M | -$1.60M | -$1.23M | -$1.04M | -$4.15M |
| Basic EPS | -$1.02 | $0.12 | -$1.09 | -- | -$2.10 | -$1.71 | -$1.86 | -- |
| **Diluted EPS** | -$1.02 | $0.06 | -$1.09 | -- | -$2.10 | -$1.71 | -$1.86 | -- |
| Basic Shares Outstanding | 1.5M | 1.3M | 1.2M | -- | 761.2K | 717.1K | 557.6K | -- |
| Diluted Shares Outstanding | 1.5M | 2.5M | 1.2M | -- | 761.2K | 717.1K | 557.6K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $762K | $3.23M | -- | $4.89M | $9.46M | $7.23M | $6.17M | $6.47M | $5.60M | $145K |
| **Cash & Short-Term Investments** | $762K | $3.23M | -- | $4.89M | $9.46M | $7.23M | $6.17M | $6.47M | $5.60M | $145K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $0 | $6.8K | $0 |
| Inventory | $0 | $0 | $2.62M | $2.64M | $1.28M | $590K | $113K | $59K | $192K | $40K |
| Other Current Assets | -- | -- | -- | -- | -- | $6.0K | $131K | $273K | $14K | $11K |
| **Total Current Assets** | $968K | $3.43M | $3.03M | $5.38M | $12.09M | $8.21M | $6.54M | $6.95M | $5.88M | $196K |
| Property, Plant & Equipment, Net | $43K | $69K | $112K | $236K | $131K | $212K | $236K | $273K | $242K | $295K |
| Other Non-Current Assets | $6.0K | $6.0K | -- | $6.0K | $6.0K | $6.0K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $2.89M | $1.02M | $3.72M | $3.89M | $781K | $557K | $641K | $273K | $242K | $295K |
| **Total Assets** | $3.85M | $4.45M | $6.75M | $9.27M | $12.87M | $8.76M | $7.18M | $7.22M | $6.12M | $491K |
| Accounts Payable | $383K | $270K | $360K | $614K | $791K | $403K | $1.28M | $631K | $780K | $228K |
| Short-Term Debt | -- | $0 | $28K | $28K | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $751K | $605K | $903K | $1.70M | $1.54M | $987K | $2.07M | $975K | $848K | $1.38M |
| Long-Term Debt | -- | -- | -- | -- | $547K | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $843K | $1.29M | $192K | $366K | $547K | $609K | $343K | $0 | $0 | $0 |
| **Total Liabilities** | $1.59M | $1.89M | $1.10M | $2.07M | $2.09M | $1.60M | $2.42M | $975K | $848K | $1.38M |
| **Total Debt (incl. Leases)** | $492K | $584K | $394K | $547K | $1.20M | $697K | $409K | -- | -- | -- |
| Common Stock | $116 | $53 | $1 | $317 | $212 | $3.4K | $842 | $742 | $392 | $72 |
| Retained Earnings | -$110.5M | -$103.4M | -$91.93M | -$81.87M | -$68.69M | -$57.34M | -$45.22M | -$27.69M | -$17.90M | -$12.52M |
| **Total Stockholders' Equity** | $2.26M | $2.56M | $5.66M | $7.20M | $10.78M | $7.17M | $4.76M | $6.25M | $5.28M | -$894K |
| Total Equity | $2.26M | $2.56M | $5.66M | $7.20M | $10.78M | $7.17M | $4.76M | $6.25M | $5.28M | -$894K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.52M | $1.74M | $356K | $762K | $794K | $1.81M | -- | $3.23M |
| **Cash & Short-Term Investments** | $1.52M | $1.74M | $356K | $762K | $794K | $1.81M | -- | $3.23M |
| Inventory | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Total Current Assets** | $5.05M | $5.59M | $537K | $968K | $1.05M | $1.85M | $2.18M | $3.43M |
| Property, Plant & Equipment, Net | $36K | $44K | $33K | $43K | $53K | $63K | $63K | $69K |
| Other Non-Current Assets | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | -- | -- | $6.0K |
| **Total Non-Current Assets** | $1.67M | $2.36M | $2.90M | $2.89M | $915K | $955K | $990K | $1.02M |
| **Total Assets** | $6.72M | $7.94M | $3.44M | $3.85M | $1.96M | $2.81M | $3.17M | $4.45M |
| Accounts Payable | $299K | $465K | $457K | $383K | $252K | $282K | $224K | $270K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $636K | $787K | $835K | $751K | $800K | $577K | $566K | $605K |
| **Total Non-Current Liabilities** | $886K | $846K | $816K | $843K | $992K | $758K | $852K | $1.29M |
| **Total Liabilities** | $1.52M | $1.63M | $1.65M | $1.59M | $1.79M | $1.33M | $1.42M | $1.89M |
| **Total Debt (incl. Leases)** | $397K | $429K | $461K | $492K | $525K | $557K | $587K | $584K |
| Common Stock | $148 | $148 | $122 | $116 | $77 | $74 | $55 | $53 |
| Retained Earnings | -$113.1M | -$111.6M | -$111.8M | -$110.5M | -$107.3M | -$105.7M | -$104.5M | -$103.4M |
| **Total Stockholders' Equity** | $5.20M | $6.31M | $1.79M | $2.26M | $171K | $1.47M | $1.75M | $2.56M |
| Total Equity | $5.20M | $6.31M | $1.79M | $2.26M | $171K | $1.47M | $1.75M | $2.56M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.03M | -$11.51M | -$10.06M | $13.18M | $11.23M | $11.73M | -$13.31M | -$9.80M | -$5.38M | -$2.78M |
| Depreciation & Amortization | $44K | $46K | $124K | $97K | $116K | $99K | $81K | $68K | $61K | $65K |
| Stock-Based Compensation | $329K | $572K | $996K | $1.20M | $1.44M | $2.10M | -- | -- | -- | -- |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $0 | $6.8K | -$6.8K | $0 |
| Change in Inventory | -- | $236K | -$116K | -$1.36M | -$695K | -$476K | -$54K | -$155K | -$152K | $59K |
| **Operating Cash Flow** | -$5.18M | -$7.40M | -$9.55M | -$12.77M | -$11.12M | -$10.75M | -$8.59M | -$7.70M | -$3.30M | -$1.32M |
| Capital Expenditure | -$17K | -$16K | -$34K | -$203K | -$45K | -$75K | -$44K | -$100K | -$7.9K | -- |
| **Free Cash Flow** | -$5.20M | -$7.42M | -$9.58M | -$12.97M | -$11.17M | -$10.82M | -$8.63M | -$7.80M | -$3.31M | -- |
| **Investing Cash Flow** | -$3.02M | -$13K | -$25K | -$203K | -$45K | -$75K | -$44K | -$100K | -$7.9K | $0 |
| Common Stock Issued | $1.22M | $5.37M | $6.48M | $8.40M | $10.62M | $6.78M | $125K | $7.74M | $8.59M | $5.0K |
| **Financing Cash Flow** | $5.73M | $7.81M | $7.52M | $8.40M | $13.40M | $11.88M | $8.34M | $8.67M | $8.77M | $1.44M |
| **Net Change in Cash** | -$2.47M | $396K | -$2.06M | -$4.57M | $2.23M | $1.05M | -- | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.53M | $160K | -$1.31M | -$3.17M | -$1.60M | -$1.23M | -$1.04M | -$4.15M |
| Depreciation & Amortization | $7.9K | $8.2K | $9.5K | $10K | $11K | $9.4K | $14K | $11K |
| Stock-Based Compensation | $357K | $542K | $574K | $13K | $145K | $40K | $83K | $105K |
| Change in Inventory | -- | -- | -- | -- | -- | $0 | $0 | $329K |
| **Operating Cash Flow** | -$1.75M | -$928K | -$1.12M | -$1.61M | -$1.16M | -$1.11M | -$1.29M | -$1.52M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | -$17K | $0 |
| **Free Cash Flow** | -- | -- | -- | -$1.61M | -$1.16M | -$1.11M | -$1.31M | -$1.52M |
| **Investing Cash Flow** | $1.15M | $2.22M | $450K | -$3.00M | $0 | $0 | -$17K | $0 |
| Common Stock Issued | $0 | $94K | $264K | $66K | $149K | $857K | $146K | $4.22M |
| **Financing Cash Flow** | $0 | $3.89M | $264K | $4.58M | $149K | $857K | $146K | $0 |
| **Net Change in Cash** | -$598K | $5.18M | -$406K | -$32K | -$1.01M | -$256K | -$1.16M | -$1.52M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 100.0% | 50.9% | 54.3% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -146080.5% | -1315.6% | -347.5% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -158669.6% | -1529.2% | -538.3% |
| Return on Equity (ROE) | -310.9% | -449.5% | -177.8% | -182.9% | -104.1% | -163.6% | -279.5% | -156.8% | -101.9% | -- |
| Return on Assets (ROA) | -182.4% | -258.5% | -148.9% | -142.1% | -87.2% | -133.8% | -185.4% | -135.6% | -87.8% | -565.5% |
| Current Ratio | 1.29x | 5.67x | 3.36x | 3.16x | 7.83x | 8.32x | 3.15x | 7.13x | 6.93x | 0.14x |
| Quick Ratio | 1.29x | 5.67x | 0.45x | 1.61x | 7.00x | 7.72x | 3.10x | 7.07x | 6.71x | 0.11x |
| Debt to Equity | 0.22x | 0.23x | 0.07x | 0.08x | 0.11x | 0.10x | 0.09x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -100.0% | -98.2% | -31.8% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -100.0% | -96.5% | -36.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -112.4% | -93.8% | -408.7% | -310.9% | -4672.2% | -595.0% | -557.3% | -449.5% |
| Return on Assets (ROA) | -87.0% | -74.5% | -212.4% | -182.4% | -407.7% | -312.2% | -308.1% | -258.5% |
| Current Ratio | 7.95x | 7.10x | 0.64x | 1.29x | 1.31x | 3.21x | 3.85x | 5.67x |
| Quick Ratio | 2.39x | 2.21x | 0.43x | 1.29x | 1.31x | 3.21x | 3.85x | 5.67x |
| Debt to Equity | 0.08x | 0.07x | 0.26x | 0.22x | 3.07x | 0.38x | 0.34x | 0.23x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
